A differentiated new player in the rapidly growing immuno-oncology market
Avvinity is deploying a powerful, proprietary and proven platform to discover and develop novel immuno-oncology therapeutics, called Alphamers, for both solid tumours and leukaemias.
© 2017 Horizon Discovery. All Rights Reserved.
Reg No. 09967702 - Unit 8100, Cambridge Research Park, Waterbeach, Cambs, CB25 9TL